ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

In Brief: Rogers On AHF Board; GAO Says Legislation May Needed For Hospice Reimbursement

March 23, 1979

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

Program Project Guidelines Available

October 27, 1995

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Dingell Subcommittee Report Next Month To Include New Info

July 1, 1994